drugset / Trial / NCT07000682
The Clinical Study on the Treatment of SSc With UTAA91 Injection.
Phase 0
Recruiting
24 enrolled
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
NaSingle-groupOpen-labelTreatment
Summary
This clinical trial is designed as a single-arm, open-label, single-center investigator-initiated early-phase study, with the primary objective of evaluating the safety of UTAA91 injection in subjects with refractory moderate-to-severe active systemic sclerosis.
Timeline
- Start
- 2025-05-30
- Primary completion
- 2027-12
- Completion
- 2040-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | UTAA91 | Cell therapy | — | — |